Investing & Markets

Make better decisions with investing tips, technical analysis, market commentary, and more

Personal Finance

Make more, save more, spend smarter, and keep more of what you earn

Business News

Stock market news & analysis


Hemispherix Trading Halted? (DNDN, CTIC, PFE, HEB)

By Admin on 07/07/2009 – 6:00 am PDTLeave a Comment

Reading some of the posts on the Yahoo message boards I see a lot of people talking about Hemispherix Biopharma (AMEX:HEB)trading is now halted. Obviously this is not true since the stock is not on the halt list.

A quick search of the HEB Yahoo message boards for the word “Halted” returns over 2,000 results with 60 of those just from July 6th! I seriously doubt we have this many members accidently thinking this stock is halted. Cell Therapeutics, Inc. (NASDAQ:CTIC) has  over 1,600 halt related posts. Dendreon Corporation (NASDAQ:DNDN) over 3,000. HEB, CTIC, and DNDN are small to mid sized companies, lets compare this to a much larger biotech company such as Pfizer Inc. (NYSE:PFE). PFE returned 182 results for the term “halted” on the Yahoo message boards. Makes you wonder why there is about a 1000% increase in halted discussion between these stocks.

Do you think people genuinely, almost every day, believe that HEB was halted. I think this is an attempt to wear people out who may already be stressed since the FDA is late on their decision. This might be why you see the share price slowly eroding every day even though not much has changed for HEB the last few weeks.

Do yourself a favor and before you ever consider opening up a message talking about if HEB is halted, check for yourself first. The two links below will show you what stocks are halted for the day and what the different halt codes mean for that stock.



If you are sick of all the inaccurate “Halted” posts on the message boards then perhaps is time you tried something new. has a free stock market forum; it is free of the usual pumpers, spammers, and trolls.

Tags: , DNDN, ,

Related Articles:

  1. Will Hemispherx Biopharma Make The Cut? (HEB)

Comments are closed.